Skip to content

The Analgesic Effect of Nitroglycerin Patch for Postoperative Pain After Total Knee Replacement

The Analgesic Efficacy of Nitroglycerin Patches for Postoperative Pain in Patients Undergoing Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00375362
Enrollment
50
Registered
2006-09-13
Start date
2006-07-31
Completion date
2006-09-30
Last updated
2006-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Keywords

nitroglycerin, morphine, patient controlled analgesia, total knee arthroplasty

Brief summary

Patients who undergo general anestheesia for total knee arthroplasty pften have sever postoperative pain which hinders their rehabilitation. Nitroglycerin patches have been found to cause alleviation of pain especially when used in conjuction with morphine. Therefore we propose placement of a nitroglycerin patch after total kneee arthroplasty surgery and see how it affects pain scores or causes less nedd for morphine after surgery.

Detailed description

Patients undergoing total knee arthroplasty will be randomized into two groups: control and placebo. Eache patient will undergo total knee arthroplasty under general anesthesia. Both groups will get the same anesthetic protocal. At the end of surgery, before awakening patients will recieve either a nitroglycerin or placebo patch on their back. Both the participant and the investigator will be blinded to the group assisignment. At the end of surgery both groups will recieve morphine for postoperative pain. In the recovery room they will be given patient controlled analgesia with morphine. An investigator blinded to study assisignment will record pain scores, sedation scores, nauseau and vomiting. Patients will be given patient controlled analgesia for 24 hours and they will be followed for pain levels, morphine use, sedation and nauseau levels. The nitroderm or placebo patch will be removed after 24 hours.

Interventions

DRUGNitroderm patch

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy patients undergoing total knee arthroplasty

Exclusion criteria

* Pshychiatric disorder * Allergy to nitroglycerin or morphine * Chronic renal failure * Migraine headaches * Hypotension

Design outcomes

Primary

MeasureTime frame
pain scores
morphine use
sedation score
nausea and vomiting

Countries

Israel

Contacts

Primary ContactArtium Lenchinsky, MD
937 6811

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026